Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1639 studies found for:    "Depressive Disorder" [DISEASE] | "Depressive Disorder, Major"
Show Display Options
Rank Status Study
21 Completed
Has Results
Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
Conditions: Depressive Disorder, Major;   Metabolic Syndrome X
Intervention: Drug: Pioglitazone
22 Completed Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Device: transcranial direct current stimulation;   Drug: Sertraline;   Other: double placebo
23 Completed An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
Condition: Depressive Disorder, Major
Intervention: Drug: Escitalopram
24 Recruiting An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Sirukumab 50 mg;   Drug: Placebo
25 Completed A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: GSK561679;   Other: Placebo
26 Completed
Has Results
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Vortioxetine;   Drug: Placebo
27 Completed A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: GW597599B;   Drug: paroxetine
28 Completed
Has Results
Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Vortioxetine;   Drug: Placebo
29 Completed
Has Results
Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Vortioxetine;   Drug: Placebo
30 Completed
Has Results
Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Vortioxetine;   Drug: Duloxetine;   Drug: Placebo
31 Suspended Predictors of Treatment Response in Late-onset Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Standard care
32 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release (DVS SR);   Drug: Placebo;   Drug: Duloxetine 60 mg/day
33 Completed An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: saredutant (SR48968);   Drug: paroxetine;   Drug: placebo
34 Completed An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Radafaxine
35 Completed Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
Condition: Depressive Disorder, Major
Intervention: Drug: Bupropion extended release
36 Completed Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Quetiapine (Seroquel) XR
37 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: desvenlafaxine succinate sustained release;   Genetic: Genotyping
38 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline
39 Completed An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Radafaxine
40 Completed CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.
Condition: Depressive Disorder, Major
Intervention: Drug: methylphenidate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years